EMEA-000828-PIP05-17

Key facts

Invented name
Jardiance
Active substance
empagliflozin
Therapeutic area
Cardiovascular diseases
Decision number
P/0216/2017
PIP number
EMEA-000828-PIP05-17
Pharmaceutical form(s)
Film-coated tablet
Condition(s) / indication(s)
Prevention of cardiovascular events in patients with chronic heart failure
Route(s) of administration
Oral use
Contact for public enquiries
Boehringer Ingelheim International GmbH
Germany
Tel. +49 6132778271
E-mail: paediatrics@boehringer-ingelheim.com
 
Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating